Tally Health LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tally Health LLC - overview
Established
2021
Location
New York, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, and founded in 2021, Tally Health LLC operates as a biotechnology company. The company was founded by David Sinclair and Whitney Casey. In April 2023, Tally Health raised USD 10 million in seed funding led by Tally Health, G9 Ventures, L Catterton, and Second Sight Ventures. As of 2023, the company’s CEO is Melanie Goldey.
Tally Health offers a longevity platform, which is a biotech aging research platform that develops anti-aging biological products to treat diseases including cancer, dementia, and cardiovascular disease. The company also provides the TallyAge™ test, which is a biological age test that improves patients’ health spans by identifying their biological age. In addition, the company sells these test kits online through its e-commerce platform. The company generates revenue by offering its services on a subscription-based pricing plan.
The plans include a monthly subscription (USD 199/month), a 6-month subscription (USD 159/month), and a 12-month subscription (USD 129/month). The company plans to use the funds raised in April 2023 to support product research and development as well as the advancement of its technology.
Current Investors
L Catterton, Forerunner Ventures, G9 Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.tallyhealth.com
Verticals
E-commerce
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.